1 study found for:    22855599 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
Condition: Leukemia
Interventions: Biological: sargramostim;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: gemtuzumab ozogamicin (GO);   Drug: Daunorubicin;   Procedure: Autologous HCT;   Procedure: Allogeneic HCT

Indicates status has not been verified in more than two years